These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30769058)

  • 21. Initial and Long-Term Results of a Microcatheter-Based Retrograde Approach for the Endovascular Treatment of Chronic Total Occlusion in Iliac or Femoropopliteal Arteries.
    Matsumi J; Takada T; Moriyama N; Ochiai T; Tobita K; Shishido K; Sugitatsu K; Mizuno S; Yamanaka F; Murakami M; Tanaka Y; Takahashi S; Akasaka T; Saito S
    Ann Vasc Surg; 2017 May; 41():176-185. PubMed ID: 28238927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endovascular interventions for TASC II D femoropopliteal lesions.
    Baril DT; Chaer RA; Rhee RY; Makaroun MS; Marone LK
    J Vasc Surg; 2010 Jun; 51(6):1406-12. PubMed ID: 20385464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-Analysis-Derived Benchmarks of Patency and Target Lesion Revascularization of Percutaneous Balloon Angioplasty from Prospective Clinical Trials of Symptomatic Femoropopliteal In-Stent Restenosis.
    Shammas NW; Jones-Miller S; Lemke J
    J Vasc Interv Radiol; 2016 Aug; 27(8):1195-203. PubMed ID: 27350033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrograde Popliteal Access to Percutaneous Peripheral Intervention for Chronic Total Occlusion of Superficial Femoral Arteries.
    Dumantepe M
    Vasc Endovascular Surg; 2017 Jul; 51(5):240-246. PubMed ID: 28595481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease.
    Ullery BW; Tran K; Itoga N; Casey K; Dalman RL; Lee JT
    J Vasc Surg; 2015 Jun; 61(6):1479-88. PubMed ID: 25704407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A single center experience of Zilver PTX for femoro-popliteal lesions.
    Kang WY; Campia U; Didier RJ; Kiramijyan S; Koifman E; Negi SI; Lipinski MJ; Baker NC; Escarcega RO; Torguson R; Waksman R; Bernardo NL
    Cardiovasc Revasc Med; 2016 Sep; 17(6):399-403. PubMed ID: 27496591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular elastography: a novel method to characterize occluded lower limb arteries prior to endovascular therapy.
    Takimura H; Hirano K; Muramatsu T; Tsukahara R; Ito Y; Sakai T; Ishimori H; Nakano M; Yamawaki M; Araki M; Kato T; Kobayashi N; Sakamoto Y; Ishii A; Takama T; Tokuda T
    J Endovasc Ther; 2014 Oct; 21(5):654-61. PubMed ID: 25290793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease.
    Chan YC; Cheng SW; Cheung GC
    J Vasc Surg; 2015 Nov; 62(5):1201-9. PubMed ID: 26169015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two-year clinical outcomes of drug-coated balloon angioplasty and angiographic predictors of restenosis among patients with de novo femoropopliteal lesions.
    Yamaguchi K; Mori S; Fukagawa T; Kishida T; Nakano T; Shirai S; Mizusawa M; Makino K; Honda Y; Tsutsumi M; Kobayashi N; Yamawaki M; Ito Y
    Indian Heart J; 2023; 75(6):403-408. PubMed ID: 37739220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents.
    Chan YC; Cheng SW; Ting AC; Cheung GC
    J Vasc Surg; 2014 Feb; 59(2):384-91. PubMed ID: 24461862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mid-Term Outcomes of Endovascular Treatment for TASC-II D Femoropopliteal Occlusive Disease with Critical Limb Ischemia.
    Torres-Blanco Á; Edo-Fleta G; Gómez-Palonés F; Molina-Nácher V; Ortiz-Monzón E
    Cardiovasc Intervent Radiol; 2016 Mar; 39(3):344-52. PubMed ID: 26202389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass.
    Lumsden AB; Morrissey NJ;
    J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year.
    Davaine JM; Quérat J; Guyomarch B; Brennan MÁ; Costargent A; Chaillou P; Patra P; Gouëffic Y
    Eur J Vasc Endovasc Surg; 2013 Aug; 46(2):201-12. PubMed ID: 23773773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of the femoropopliteal artery with the bioresorbable REMEDY stent.
    Bontinck J; Goverde P; Schroë H; Hendriks J; Maene L; Vermassen F
    J Vasc Surg; 2016 Nov; 64(5):1311-1319. PubMed ID: 27462002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study.
    Laird JR; Yeo KK; Rocha-Singh K; Das T; Joye J; Dippel E; Reddy B; Botti C; Jaff MR
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):852-9. PubMed ID: 22422738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cryoplasty as endovascular treatment in the femoropopliteal region: hemodynamic results and follow-up at one year.
    Gonzalo B; Solanich T; Bellmunt S; Herranz C; González E; Arnedo G; Muñoz G; Florit S; Hospedales J; Lloret MD; Vallespín J; Giménez A
    Ann Vasc Surg; 2010 Jul; 24(5):680-5. PubMed ID: 20409679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin-bonded expanded polytetrafluoroethylene femoropopliteal bypass grafts outperform expanded polytetrafluoroethylene grafts without heparin in a long-term comparison.
    Samson RH; Morales R; Showalter DP; Lepore MR; Nair DG
    J Vasc Surg; 2016 Sep; 64(3):638-47. PubMed ID: 27139782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Balloon Angioplasty Versus Bailout Stenting for Isolated Chronic Total Occlusions in the Popliteal Artery.
    Elens M; Verhelst R; Mastrobuoni S; Bosiers MJ; Possoz J; Lacroix V; Astarci P
    Vasc Endovascular Surg; 2019 Feb; 53(2):126-131. PubMed ID: 30466371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of runoff grade after endovascular therapy for femoropopliteal lesions.
    Hiramori S; Soga Y; Tomoi Y; Tosaka A
    J Vasc Surg; 2014 Mar; 59(3):720-7. PubMed ID: 24377941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shared and differential factors influencing restenosis following endovascular therapy between TASC (Trans-Atlantic Inter-Society Consensus) II class A to C and D lesions in the femoropopliteal artery.
    Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
    JACC Cardiovasc Interv; 2014 Jul; 7(7):792-8. PubMed ID: 25060024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.